Guardant Health Inc
NASDAQ:GH
Guardant Health Inc
NASDAQ:GH
Price:
87.17
USD
-6.11%
Market Closed
Market Cap:
$11.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Guardant Health Inc
NASDAQ:GH
|
US |
|
Nazara Technologies Ltd
NSE:NAZARA
|
IN |
|
B
|
Bakrie Telecom Tbk PT
IDX:BTEL
|
ID |
|
E
|
E Star Commercial Management Co Ltd
HKEX:6668
|
CN |
|
R
|
Rosebank Industries PLC
LSE:ROSE
|
UK |
|
Arcelormittal South Africa Ltd
OTC:ARCXF
|
ZA |
|
Shilpa Medicare Ltd
NSE:SHILPAMED
|
IN |
|
Appier Group Inc
OTC:APPIF
|
JP |
|
A
|
Apollo Sindoori Hotels Ltd
NSE:APOLSINHOT
|
IN |
Balance Sheet
Balance Sheet Decomposition
Guardant Health Inc
Guardant Health Inc
Balance Sheet Decomposition is not available for
Guardant Health Inc
Guardant Health Inc
Balance Sheet
Guardant Health Inc
Guardant Health Inc
Currency: USD
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
34
|
72
|
141
|
143
|
833
|
492
|
142
|
1 134
|
526
|
378
|
|
| Cash Equivalents |
34
|
72
|
141
|
143
|
833
|
492
|
142
|
1 134
|
526
|
378
|
|
| Short-Term Investments |
62
|
149
|
278
|
380
|
962
|
441
|
870
|
35
|
314
|
823
|
|
| Total Receivables |
4
|
13
|
36
|
48
|
53
|
98
|
97
|
89
|
110
|
138
|
|
| Accounts Receivables |
4
|
13
|
36
|
48
|
53
|
98
|
97
|
89
|
110
|
138
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
3
|
7
|
9
|
15
|
23
|
31
|
52
|
62
|
71
|
86
|
|
| Other Current Assets |
2
|
2
|
5
|
11
|
18
|
53
|
32
|
28
|
34
|
41
|
|
| Total Current Assets |
103
|
243
|
469
|
597
|
1 888
|
1 114
|
1 192
|
1 347
|
1 055
|
1 466
|
|
| PP&E Net |
13
|
16
|
31
|
73
|
100
|
314
|
342
|
303
|
279
|
305
|
|
| PP&E Gross |
13
|
16
|
31
|
73
|
100
|
314
|
342
|
303
|
279
|
305
|
|
| Accumulated Depreciation |
7
|
11
|
17
|
22
|
34
|
55
|
88
|
127
|
166
|
199
|
|
| Intangible Assets |
0
|
0
|
0
|
9
|
16
|
14
|
12
|
9
|
7
|
26
|
|
| Goodwill |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
77
|
|
| Long-Term Investments |
0
|
73
|
78
|
269
|
247
|
698
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
1
|
11
|
10
|
12
|
17
|
61
|
62
|
124
|
141
|
140
|
|
| Other Assets |
0
|
0
|
0
|
3
|
3
|
3
|
3
|
3
|
3
|
77
|
|
| Total Assets |
117
N/A
|
343
+194%
|
587
+71%
|
963
+64%
|
2 272
+136%
|
2 205
-3%
|
1 610
-27%
|
1 786
+11%
|
1 486
-17%
|
2 014
+36%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
3
|
5
|
11
|
16
|
7
|
18
|
69
|
52
|
39
|
54
|
|
| Accrued Liabilities |
4
|
10
|
19
|
41
|
46
|
84
|
107
|
136
|
152
|
198
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
7
|
4
|
18
|
15
|
13
|
94
|
17
|
18
|
35
|
51
|
|
| Total Current Liabilities |
14
|
20
|
47
|
73
|
67
|
195
|
193
|
206
|
226
|
303
|
|
| Long-Term Debt |
17
|
1
|
0
|
0
|
806
|
1 135
|
1 137
|
1 140
|
1 143
|
1 504
|
|
| Minority Interest |
0
|
0
|
42
|
50
|
57
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
6
|
14
|
15
|
42
|
43
|
230
|
219
|
282
|
257
|
306
|
|
| Total Liabilities |
37
N/A
|
34
-7%
|
104
+204%
|
164
+57%
|
973
+493%
|
1 560
+60%
|
1 550
-1%
|
1 628
+5%
|
1 625
0%
|
2 113
+30%
|
|
| Equity | |||||||||||
| Common Stock |
180
|
500
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
108
|
196
|
281
|
353
|
607
|
1 008
|
1 662
|
2 142
|
2 578
|
2 995
|
|
| Additional Paid In Capital |
7
|
5
|
764
|
1 150
|
1 902
|
1 658
|
1 742
|
2 304
|
2 444
|
2 900
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
0
|
1
|
3
|
5
|
20
|
4
|
5
|
5
|
|
| Total Equity |
80
N/A
|
309
+287%
|
483
+57%
|
798
+65%
|
1 299
+63%
|
645
-50%
|
60
-91%
|
159
+164%
|
140
N/A
|
99
+29%
|
|
| Total Liabilities & Equity |
117
N/A
|
343
+194%
|
587
+71%
|
963
+64%
|
2 272
+136%
|
2 205
-3%
|
1 610
-27%
|
1 786
+11%
|
1 486
-17%
|
2 014
+36%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
84
|
84
|
86
|
94
|
100
|
100
|
103
|
122
|
124
|
131
|
|
Switch to:
Switch to:
See Also
Discover More
